Search by Drug Name or NDC

    NDC 00085-2224-02 NOXAFIL 300 mg/1 Details

    NOXAFIL 300 mg/1

    NOXAFIL is a ORAL POWDER, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is POSACONAZOLE.

    Product Information

    NDC 00085-2224
    Product ID 0085-2224_50e517fb-4c04-4639-9359-e20907ca822e
    Associated GPIs
    GCN Sequence Number 082351
    GCN Sequence Number Description posaconazole SUSPDR PKT 300 MG ORAL
    HIC3 W3B
    HIC3 Description ANTIFUNGAL AGENTS
    GCN 49744
    HICL Sequence Number 033461
    HICL Sequence Number Description POSACONAZOLE
    Brand/Generic Brand
    Proprietary Name NOXAFIL
    Proprietary Name Suffix n/a
    Non-Proprietary Name posaconazole
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form POWDER, FOR SUSPENSION
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name POSACONAZOLE
    Labeler Name Merck Sharp & Dohme LLC
    Pharmaceutical Class Azole Antifungal [EPC], Azoles [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA214770
    Listing Certified Through 2024-12-31

    Package

    NDC 00085-2224-02 (00085222402)

    NDC Package Code 0085-2224-02
    Billing NDC 00085222402
    Package 8 PACKET in 1 CARTON (0085-2224-02) / 1 POWDER, FOR SUSPENSION in 1 PACKET (0085-2224-01)
    Marketing Start Date 2021-06-08
    NDC Exclude Flag N
    Pricing Information N/A